Literature DB >> 26633129

Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown.

Nicole Bäumer1, Neele Appel1, Lisa Terheyden1, Frank Buchholz2, Claudia Rossig3, Carsten Müller-Tidow1,4, Wolfgang E Berdel1, Sebastian Bäumer1.   

Abstract

Knockdown of genes by RNA interference (RNAi) in vitro requires methods of transfection or transduction, both of which have limited impact in vivo. As a virus-free approach, we chemically coupled cell surface receptors internalizing antibodies to the short interfering RNA (siRNA) carrier peptide protamine using the bispecific cross-linker sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate). First, protamine was conjugated amino-terminally to sulfo-SMCC, and then this conjugate was coupled via cysteine residues to the IgG backbone to carry siRNA. This complex can efficiently find, bind and internalize into receptor-positive cells in vitro and in vivo, which can be checked by flow cytometry, fluorescence microscopy and western blotting. This method obtains results similar to those of siRNA targeting molecules engineered by genetic fusions between receptor-binding and siRNA carrier units, with the advantage of using readily available purified proteins without the need for engineering, expression and purification of respective constructs. The procedure for coupling the complex takes ∼ 2 d, and the functional assays take ∼ 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26633129     DOI: 10.1038/nprot.2015.137

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  27 in total

Review 1.  Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.

Authors:  Bin Liu
Journal:  Brief Funct Genomic Proteomic       Date:  2007-07-31

2.  A simple protocol for paraffin-embedded myelin sheath staining with osmium tetroxide for light microscope observation.

Authors:  Federica Di Scipio; Stefania Raimondo; Pierluigi Tos; Stefano Geuna
Journal:  Microsc Res Tech       Date:  2008-07       Impact factor: 2.769

3.  Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L).

Authors:  L H Mayeenuddin; Y Yu; Z Kang; L J Helman; L Cao
Journal:  Oncogene       Date:  2010-09-06       Impact factor: 9.867

Review 4.  Current progress of siRNA/shRNA therapeutics in clinical trials.

Authors:  John C Burnett; John J Rossi; Katrin Tiemann
Journal:  Biotechnol J       Date:  2011-07-11       Impact factor: 4.677

5.  Monoclonal antibody alpha IR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding.

Authors:  G Steele-Perkins; R A Roth
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

6.  In vivo shRNA screens in solid tumors.

Authors:  Gaetano Gargiulo; Michela Serresi; Matteo Cesaroni; Danielle Hulsman; Maarten van Lohuizen
Journal:  Nat Protoc       Date:  2014-11-20       Impact factor: 13.491

7.  Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.

Authors:  Yan-dan Yao; Tian-meng Sun; Song-yin Huang; Shuang Dou; Ling Lin; Jia-ning Chen; Jian-bin Ruan; Cheng-qiong Mao; Feng-yan Yu; Mu-sheng Zeng; Jian-ye Zang; Qiang Liu; Feng-xi Su; Peter Zhang; Judy Lieberman; Jun Wang; Erwei Song
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

8.  The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.

Authors:  Young-Suk Choi; Jue Yeon Lee; Jin Sook Suh; Young-Min Kwon; Seung-Jin Lee; Jun-Key Chung; Dong-Soo Lee; Victor C Yang; Chong-Pyoung Chung; Yoon-Jeong Park
Journal:  Biomaterials       Date:  2009-12-01       Impact factor: 12.479

9.  T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Authors:  Priti Kumar; Hong-Seok Ban; Sang-Soo Kim; Haoquan Wu; Todd Pearson; Dale L Greiner; Amale Laouar; Jiahong Yao; Viraga Haridas; Katsuyoshi Habiro; Yong-Guang Yang; Ji-Hoon Jeong; Kuen-Yong Lee; Yong-Hee Kim; Sung Wan Kim; Matthias Peipp; Georg H Fey; N Manjunath; Leonard D Shultz; Sang-Kyung Lee; Premlata Shankar
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

10.  Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

Authors:  Dan Peer; Pengcheng Zhu; Christopher V Carman; Judy Lieberman; Motomu Shimaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

View more
  19 in total

Review 1.  The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

Authors:  Ulrich H Weidle; Steffen Dickopf; Corinna Hintermair; Gwendlyn Kollmorgen; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

Review 2.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

3.  Template-Catalyzed, Disulfide Conjugation of Monoclonal Antibodies Using a Natural Amino Acid Tag.

Authors:  Jeremy D King; Yuelong Ma; Yi-Chiu Kuo; Krzysztof P Bzymek; Leah H Goodstein; Kassondra Meyer; Roger E Moore; Desiree Crow; David M Colcher; Gagandeep Singh; David A Horne; John C Williams
Journal:  Bioconjug Chem       Date:  2018-05-25       Impact factor: 4.774

Review 4.  Protamine-Based Strategies for RNA Transfection.

Authors:  Natalia Teresa Jarzebska; Mark Mellett; Julia Frei; Thomas M Kündig; Steve Pascolo
Journal:  Pharmaceutics       Date:  2021-06-14       Impact factor: 6.321

5.  A novel excision selection method for isolation of antibodies binding antigens expressed specifically by rare cells in tissue sections.

Authors:  Simon Lykkemark; Ole Aalund Mandrup; Mads Bjørnkjær Jensen; Jesper Just; Peter Kristensen
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

6.  Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy.

Authors:  Samuel Cota Teixeira; Daiana Silva Lopes; Sarah Natalie Cirilo Gimenes; Thaise Lara Teixeira; Marcelo Santos da Silva; Rebecca Tavares E Silva Brígido; Felipe Andrés Cordero da Luz; Aline Alves da Silva; Makswell Almeida Silva; Pilar Veras Florentino; Paula Cristina Brígido Tavares; Marlus Alves Dos Santos; Veridiana de Melo Rodrigues Ávila; Marcelo José Barbosa Silva; Maria Carolina Elias; Renato Arruda Mortara; Claudio Vieira da Silva
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

7.  Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells.

Authors:  Amy E Arnold; Elise Malek-Adamian; Phuong U Le; Anika Meng; Saúl Martínez-Montero; Kevin Petrecca; Masad J Damha; Molly S Shoichet
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-19       Impact factor: 8.886

8.  Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth.

Authors:  Nicole Bäumer; Jan Rehkämper; Neele Appel; Lisa Terheyden; Wolfgang Hartmann; Eva Wardelmann; Frank Buchholz; Carsten Müller-Tidow; Wolfgang E Berdel; Sebastian Bäumer
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

9.  Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.

Authors:  Sheng-Jia Shi; Li-Juan Wang; Dong-Hui Han; Jie-Heng Wu; Dian Jiao; Kai-Liang Zhang; Jiang-Wei Chen; Yu Li; Fa Yang; Jing-Liang Zhang; Guo-Xu Zheng; An-Gang Yang; Ai-Zhi Zhao; Wei-Jun Qin; Wei-Hong Wen
Journal:  Theranostics       Date:  2019-02-07       Impact factor: 11.556

10.  Tumor-Cell-Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody-Inhibitor Conjugates (AiCs).

Authors:  Andreas Faust; Nicole Bäumer; Alina Schlütermann; Manuel Becht; Lilo Greune; Christiane Geyer; Christian Rüter; Renato Margeta; Lisa Wittmann; Petra Dersch; Georg Lenz; Wolfgang E Berdel; Sebastian Bäumer
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-25       Impact factor: 16.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.